H.R. 4626 · 118th Congress
OTC Act of 2023
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 118th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
Miller-MeeksSponsor10 cosponsors · 10 R
R
Bice
LC
R
Chavez-DeRemer
MG
R
Greene
DH
R
Harshbarger
YK
R
Kim
JK
R
Kiggans
NM
R
Mace
NM
R
Malliotakis
MS
R
Salazar
AH
R
Hinson9 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Orally Taken Contraception Act of 2023 or the OTC Act of 2023
What it does: CRS summary · Introduced in House · Jul 13, 2023
Orally Taken Contraception Act of 2023 or the OTC Act of 2023
This bill requires the Food and Drug Administration (FDA) to issue guidance on the approval process for over-the-counter oral contraceptives so as to encourage drug manufacturers to submit applications for approval. The FDA must also evaluate (1) whether and to what extent consumers understand the labeling on oral contraceptives, and (2) whether the labeling could be improved.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: OTC Act of 2023
Also known as: Orally Taken Contraception Act of 2023
Latest action (Jul 14, 2023): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Jul 13, 2023
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.